glp 1 release GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Schematic pathway showing release of

Scientific evidence[14,15] of the critical role of serotonin in the pathogenesis of depression was instrumental to the development of some of the current antidepressant drugs (fluoxetine and sertraline [SERT]) that selectively inhibit the reuptake of serotonin at serotonin transporters, and thereby increase serotonin concentration within the synaptic cleft[15,16]

Slowed aging associated with the risk of allcause mortality in 34% of participants as measured by the PCGrimAge epigenetic clock

When protein, fiber, and healthy fats arrive together in specific ratios, they create a synergistic activation effect stronger than any single nutrient alone

Emerging Non-Diabetic Applications Anti-inflammatory Effects: DPP-4 inhibitors can modify the immune response to start in a manner with an additional line [36]